| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.36B | 22.13B | 22.31B | 21.32B | 20.52B | 20.23B |
| Gross Profit | 4.80B | 4.35B | 4.17B | 3.66B | 3.30B | 2.94B |
| EBITDA | 4.36B | 4.21B | 4.14B | 3.72B | 3.42B | 2.99B |
| Net Income | 1.19B | 1.15B | 1.02B | 676.00M | 519.00M | 187.00M |
Balance Sheet | ||||||
| Total Assets | 89.79B | 90.86B | 90.64B | 91.09B | 92.60B | 92.89B |
| Cash, Cash Equivalents and Short-Term Investments | 1.48B | 1.05B | 1.47B | 1.44B | 1.26B | 1.37B |
| Total Debt | 54.66B | 55.73B | 56.25B | 58.74B | 60.66B | 62.24B |
| Total Liabilities | 65.82B | 67.32B | 67.69B | 69.85B | 71.97B | 72.72B |
| Stockholders Equity | 23.96B | 23.54B | 22.94B | 21.24B | 20.63B | 20.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 355.00M | 1.93B | 1.65B | 1.08B | -652.00M |
| Operating Cash Flow | 0.00 | 2.96B | 3.78B | 3.42B | 2.81B | 1.88B |
| Investing Cash Flow | 0.00 | -2.02B | -1.32B | -1.35B | -1.07B | -1.36B |
| Financing Cash Flow | 0.00 | -1.36B | -2.44B | -1.89B | -1.84B | -328.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥14.41B | 7.70 | ― | 0.26% | 1.75% | -8.92% | |
78 Outperform | ¥347.13B | 9.85 | ― | 1.61% | 6.55% | -12.49% | |
73 Outperform | ¥243.12B | 4.69 | 12.70% | 1.68% | 8.29% | 24.94% | |
65 Neutral | ¥18.86B | -109.80 | ― | 1.33% | 1.70% | 1841.47% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥45.59B | 14.50 | ― | 2.17% | 4.37% | 54.12% | |
59 Neutral | ¥20.01B | 9.88 | ― | 0.81% | 1.24% | 19.78% |